One-dose CanSinoBIO vaccine to reach 300m shots annually: company
CanSino Biologics (CanSinoBIO) is expected to increase the annual production capacity of its recombinant adenovirus vector COVID-19 vaccine - the only single-dose vaccine approved in China - to 200 to…